Index -
P/E -
EPS (ttm) -29.22
Insider Own 4.43%
Shs Outstand 17.72M
Perf Week -3.67%
Market Cap 362.17M
Forward P/E -
EPS next Y -3.83
Insider Trans -27.91%
Shs Float 16.94M
Perf Month 4.65%
Income -113.81M
PEG -
EPS next Q -0.98
Inst Own 83.07%
Short Float 3.33%
Perf Quarter 135.95%
Sales 115.27M
P/S 3.14
EPS this Y 80.74%
Inst Trans 13.31%
Short Ratio 2.71
Perf Half Y 10.89%
Book/sh 9.37
P/B 2.18
EPS next Y 25.82%
ROA -35.16%
Short Interest 0.56M
Perf Year -70.41%
Cash/sh 10.68
P/C 1.92
EPS next 5Y 48.44%
ROE -86.53%
52W Range 5.85 - 72.60
Perf YTD 22.88%
Dividend Est. -
P/FCF -
EPS past 5Y -4.06%
ROIC -42.76%
52W High -71.82%
Beta 2.15
Dividend TTM -
Quick Ratio 6.74
Sales past 5Y 49.79%
Gross Margin 35.97%
52W Low 249.74%
ATR (14) 1.46
Dividend Ex-Date -
Current Ratio 8.37
EPS Y/Y TTM 42.34%
Oper. Margin -79.35%
RSI (14) 63.90
Volatility 1.84% 3.96%
Employees -
Debt/Eq 0.58
Sales Y/Y TTM -7.84%
Profit Margin -98.74%
Recom 1.80
Target Price 26.50
Option/Short Yes / Yes
LT Debt/Eq 0.57
EPS Q/Q 68.88%
Payout -
Rel Volume 1.40
Prev Close 19.96
Sales Surprise 7.15%
EPS Surprise -242.86%
Sales Q/Q 5.62%
Earnings May 07 AMC
Avg Volume 208.47K
Price 20.46
SMA20 5.43%
SMA50 34.44%
SMA200 63.90%
Trades
Volume 286,363
Change 2.51%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-08-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$6 → $3
Jun-21-24 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$5 → $6
Apr-08-24 Initiated
BTIG Research
Buy
$6
Apr-05-24 Upgrade
CL King
Neutral → Buy
$6
Jan-12-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$14 → $6
Oct-13-23 Downgrade
BofA Securities
Buy → Underperform
$32 → $3
Aug-17-23 Initiated
CL King
Neutral
Nov-11-22 Initiated
RBC Capital Mkts
Outperform
$23
Jul-14-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$48 → $20
Mar-02-22 Resumed
BofA Securities
Buy
$50
Feb-17-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$50
Aug-18-21 Initiated
Cowen
Outperform
$70
Apr-19-21 Initiated
Wells Fargo
Overweight
$63
Dec-16-20 Initiated
Oppenheimer
Perform
Oct-12-20 Initiated
SVB Leerink
Mkt Perform
$60
Oct-12-20 Initiated
Stifel
Buy
$54
Oct-12-20 Initiated
Morgan Stanley
Equal-Weight
$48
Oct-12-20 Initiated
Goldman
Buy
$54
Oct-12-20 Initiated
BofA Securities
Buy
$54
Oct-12-20 Initiated
Barclays
Overweight
Show Previous Ratings
Jun-05-25 09:05AM
Jun-03-25 04:30PM
May-29-25 05:04PM
May-14-25 09:00AM
May-09-25 09:00AM
09:50AM
Loading…
May-08-25 09:50AM
(Thomson Reuters StreetEvents) +35.26%
03:37AM
May-07-25 09:30PM
05:25PM
04:02PM
May-05-25 07:00AM
May-01-25 06:25PM
Apr-21-25 09:55AM
Apr-16-25 04:32PM
10:38AM
05:00AM
Loading…
05:00AM
Apr-02-25 09:55AM
Mar-21-25 06:35AM
Mar-18-25 08:30AM
Feb-26-25 09:55AM
Feb-24-25 04:03PM
Feb-20-25 02:14PM
(Thomson Reuters StreetEvents)
02:13AM
Feb-19-25 05:15PM
04:03PM
05:00AM
Feb-13-25 04:35PM
(GlobeNewswire) +5.12%
+9.65%
Feb-12-25 10:00AM
Feb-03-25 09:00AM
Jan-08-25 09:00AM
05:29AM
Loading…
Jan-07-25 05:29AM
Jan-06-25 08:30AM
Nov-15-24 09:00AM
Nov-11-24 10:05AM
Nov-07-24 04:00PM
Nov-06-24 05:25PM
04:02PM
Nov-05-24 08:09AM
Oct-23-24 04:05PM
09:00AM
Oct-18-24 04:25AM
Oct-16-24 06:56PM
Oct-14-24 01:27PM
Oct-11-24 06:45AM
Sep-27-24 08:26AM
Sep-23-24 03:57PM
Sep-20-24 09:13AM
Sep-17-24 05:45AM
Sep-13-24 05:45AM
Sep-12-24 01:23AM
01:14AM
01:08AM
Sep-11-24 03:44PM
Sep-09-24 04:10PM
Sep-06-24 01:47PM
Sep-04-24 03:23PM
Sep-03-24 11:57AM
Aug-31-24 05:52PM
Aug-26-24 09:00PM
Aug-07-24 06:35PM
04:03PM
Jul-31-24 10:01AM
Jul-24-24 09:00AM
Jul-01-24 06:00AM
Jun-10-24 12:00PM
Jun-03-24 04:05PM
May-13-24 06:59AM
May-10-24 03:48PM
May-09-24 03:44PM
09:42AM
(Thomson Reuters StreetEvents)
03:57AM
May-08-24 08:58PM
05:45PM
04:02PM
May-06-24 08:48AM
08:00AM
May-03-24 09:43AM
May-01-24 04:30PM
(Business Wire) +12.65%
+5.26%
Apr-19-24 08:30AM
Apr-18-24 01:36PM
Apr-17-24 08:30AM
Apr-15-24 08:30AM
Mar-13-24 04:02PM
Mar-05-24 03:34PM
(The Wall Street Journal)
Feb-26-24 09:00AM
Feb-22-24 10:51AM
07:10AM
(Thomson Reuters StreetEvents)
Feb-21-24 04:49PM
04:05PM
Feb-20-24 04:25PM
Feb-05-24 10:00AM
08:30AM
Jan-08-24 08:30AM
Jan-03-24 08:30AM
Nov-29-23 04:05PM
Nov-25-23 11:43AM
Nov-23-23 06:30AM
Nov-16-23 02:46PM
Nov-09-23 04:05PM
Nov-07-23 04:31PM
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Trigg Leslie Chair and CEO May 15 '25 Sale 17.80 935 16,643 58,129 May 16 05:24 PM Nash Marc SVP Operations and R&D May 15 '25 Sale 17.82 252 4,491 13,465 May 16 05:22 PM Brottem John L. General Counsel May 15 '25 Sale 17.82 396 7,057 11,273 May 16 05:21 PM Ahmed Nabeel Chief Financial Officer May 15 '25 Sale 17.81 584 10,401 16,096 May 16 05:20 PM Ahmed Nabeel Officer May 15 '25 Proposed Sale 17.82 584 10,405 May 15 06:07 PM Trigg Leslie Officer May 15 '25 Proposed Sale 17.80 935 16,646 May 15 05:57 PM Brottem John L. Officer May 15 '25 Proposed Sale 17.82 396 7,058 May 15 05:48 PM Nash Marc Officer May 15 '25 Proposed Sale 17.82 252 4,490 May 15 05:48 PM Trigg Leslie Chair and CEO Feb 18 '25 Sale 0.90 14,611 13,150 880,969 Feb 19 04:30 PM Nash Marc SVP Operations and R&D Feb 18 '25 Sale 0.90 4,204 3,784 200,764 Feb 19 04:29 PM Brottem John L. General Counsel Feb 18 '25 Sale 0.90 6,145 5,530 175,043 Feb 19 04:26 PM Ahmed Nabeel Chief Financial Officer Feb 18 '25 Sale 0.90 8,659 7,793 250,210 Feb 19 04:23 PM Trigg Leslie Officer Feb 18 '25 Proposed Sale 0.90 14,611 13,150 Feb 18 07:18 PM Nash Marc Officer Feb 18 '25 Proposed Sale 0.90 4,204 3,784 Feb 18 06:54 PM Brottem John L. Officer Feb 18 '25 Proposed Sale 0.90 6,145 5,530 Feb 18 06:52 PM Ahmed Nabeel Officer Feb 18 '25 Proposed Sale 0.90 8,659 7,793 Feb 18 06:51 PM Trigg Leslie Chair and CEO Jan 21 '25 Sale 0.80 65,236 52,189 895,580 Jan 22 06:05 PM Nash Marc SVP Operations and R&D Jan 21 '25 Sale 0.80 23,221 18,577 204,968 Jan 22 06:04 PM Brottem John L. General Counsel Jan 21 '25 Sale 0.80 32,930 26,344 181,188 Jan 22 06:03 PM Ahmed Nabeel Chief Financial Officer Jan 21 '25 Sale 0.80 34,288 27,430 258,869 Jan 22 06:02 PM Trigg Leslie Officer Jan 21 '25 Proposed Sale 0.80 65,236 52,189 Jan 21 06:13 PM Nash Marc Officer Jan 21 '25 Proposed Sale 0.80 23,221 18,577 Jan 21 06:10 PM Brottem John L. Officer Jan 21 '25 Proposed Sale 0.80 32,930 26,344 Jan 21 06:09 PM Ahmed Nabeel Officer Jan 21 '25 Proposed Sale 0.80 34,288 27,430 Jan 21 06:06 PM Trigg Leslie Chair and CEO Jan 13 '25 Sale 0.81 33,227 26,914 861,397 Jan 13 06:51 PM Nash Marc SVP Operations and R&D Jan 13 '25 Sale 0.81 15,011 12,159 222,291 Jan 13 06:36 PM Brottem John L. General Counsel Jan 13 '25 Sale 0.81 20,492 16,599 205,028 Jan 13 06:34 PM Ahmed Nabeel Chief Financial Officer Jan 13 '25 Sale 0.81 29,031 23,515 279,901 Jan 13 06:32 PM Trigg Leslie Officer Jan 13 '25 Proposed Sale 0.81 33,227 26,914 Jan 13 06:28 PM Nash Marc Officer Jan 13 '25 Proposed Sale 0.81 15,011 12,159 Jan 13 06:20 PM Brottem John L. Officer Jan 13 '25 Proposed Sale 0.81 20,492 16,599 Jan 13 05:59 PM Ahmed Nabeel Officer Jan 13 '25 Proposed Sale 0.81 29,031 23,515 Jan 13 05:46 PM Trigg Leslie Chair and CEO Jan 07 '25 Sale 1.29 10,227 13,193 894,624 Jan 07 07:32 PM Nash Marc SVP Operations and R&D Jan 07 '25 Sale 1.29 720 929 237,302 Jan 07 07:28 PM Brottem John L. General Counsel Jan 07 '25 Sale 1.29 1,572 2,028 225,520 Jan 07 07:26 PM Ahmed Nabeel Chief Financial Officer Jan 07 '25 Sale 1.29 1,835 2,367 308,932 Jan 07 07:24 PM Trigg Leslie Officer Jan 07 '25 Proposed Sale 1.29 10,227 13,193 Jan 07 07:04 PM Nash Marc Officer Jan 07 '25 Proposed Sale 1.29 720 929 Jan 07 06:55 PM Brottem John L. Officer Jan 07 '25 Proposed Sale 1.29 1,572 2,028 Jan 07 06:27 PM Ahmed Nabeel Officer Jan 07 '25 Proposed Sale 1.29 1,835 2,367 Jan 07 06:07 PM Trigg Leslie Chair and CEO Nov 15 '24 Sale 0.80 5,645 4,516 904,851 Nov 18 05:49 PM Nash Marc SVP Operations and R&D Nov 15 '24 Sale 0.80 1,375 1,100 238,022 Nov 18 05:48 PM Brottem John L. General Counsel Nov 15 '24 Sale 0.80 3,203 2,562 227,092 Nov 18 05:45 PM Ahmed Nabeel Chief Financial Officer Nov 15 '24 Sale 0.80 4,221 3,377 310,767 Nov 18 05:44 PM Trigg Leslie Officer Nov 15 '24 Proposed Sale 0.80 5,645 4,516 Nov 15 07:26 PM Nash Marc Officer Nov 15 '24 Proposed Sale 0.80 1,375 1,100 Nov 15 07:25 PM Brottem John L. Officer Nov 15 '24 Proposed Sale 0.80 3,203 2,562 Nov 15 07:23 PM Ahmed Nabeel Officer Nov 15 '24 Proposed Sale 0.80 4,221 3,377 Nov 15 07:22 PM Trigg Leslie Chair and CEO Aug 15 '24 Sale 0.84 5,308 4,459 910,496 Aug 15 08:02 PM Nash Marc SVP Operations and R&D Aug 15 '24 Sale 0.84 1,293 1,086 239,397 Aug 15 08:01 PM Brottem John L. General Counsel Aug 15 '24 Sale 0.84 3,011 2,529 230,295 Aug 15 07:59 PM Ahmed Nabeel Chief Financial Officer Aug 15 '24 Sale 0.84 3,971 3,336 314,988 Aug 15 07:57 PM Trigg Leslie Officer Aug 15 '24 Proposed Sale 0.84 5,308 4,459 Aug 15 06:49 PM Nash Marc Officer Aug 15 '24 Proposed Sale 0.84 1,293 1,086 Aug 15 06:49 PM Brottem John L. Officer Aug 15 '24 Proposed Sale 0.84 3,011 2,529 Aug 15 06:47 PM Ahmed Nabeel Officer Aug 15 '24 Proposed Sale 0.84 3,971 3,336 Aug 15 06:46 PM Nash Marc SVP Operations and R&D Jul 24 '24 Sale 4.02 723 2,906 240,690 Jul 24 07:08 PM